The First Affiliated Hospital Of Zhengzhou University
Clinical trials sponsored by The First Affiliated Hospital Of Zhengzhou University, explained in plain language.
-
New combo therapy aims to boost stomach cancer treatment
Disease control Recruiting nowThis study tests whether adding extra drugs to standard chemo and immunotherapy can help people with advanced stomach cancer. About 78 adults with stage III or IV stomach cancer will receive SHR1701 plus chemotherapy, along with either an EZH2 inhibitor or an anti-angiogenic drug…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated May 17, 2026 03:41 UTC
-
Balloons may beat stents for tough heart blockages
Disease control Recruiting nowThis study compares two treatments for people with completely blocked heart arteries (chronic total occlusions). One uses a drug-coated balloon to open the blockage, sometimes with a stent; the other uses a stent alone. The goal is to see if the balloon approach works as well or …
Phase: NA • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Massive study aims to cut liver cancer in hepatitis b patients
Knowledge-focused Recruiting nowThis study will follow 15,000 adults with chronic hepatitis B across 200 hospitals in China. Researchers will look at how different treatments affect liver cancer rates and other health outcomes. The goal is to find the best ways to manage the disease and work toward a cure.
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Knowledge-focused
Last updated May 17, 2026 03:55 UTC